Outcome for patients with malignant pleural mesothelioma referred for trimodality therapy in Western Australia

Journal of Thoracic Oncology

Volumn 4, Issue 8, 2009, Pages 1010-1016

  Hasani, Arman ^a   Alvarez, John M ^a   Wyatt, Jenny Ma ^a   Bydder, Sean ^a   Millward, Michael ^a,b   Byrne, Michael ^a,b   Musk, Arthur W ^a   Nowak, Anna K ^a,b  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Mesothelioma; Surgical staging; Trimodality

Indexed keywords

CISPLATIN; GEMCITABINE; PEMETREXED;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; AUSTRALIA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; LAPAROSCOPY; LUNG EMBOLISM; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MEDIASTINOSCOPY; NAUSEA; PLEURA MESOTHELIOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; THORACOSCOPY; TRIMODALITY THERAPY; VOMITING;

EID: 68349110548     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181ae25bf     Document Type: Article

References (23)

1. Vogelzang N, Rusthoven J, Symanowski J, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003;21: 2636-2644. (Pubitemid 46606305)
2. Sugarbaker D, Flores R, Jaklitsch M, et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 1999;117:54-63; discussion 63-65. (Pubitemid 29022249)
3. Treasure T, Utley M. Ten traps for the unwary in surgical series: a case study in mesothelioma reports. J Thorac Cardiovasc Surg 2007;133: 1414-1418. (Pubitemid 46805160)
4. Rea F, Marulli G, Bortolotti L, et al. Induction chemotherapy, extrapleural pneumonectomy (EPP) and adjuvant hemi-thoracic radiation in malignant pleural mesothelioma (MPM): feasibility and results. Lung Cancer 2007;57:89-95. (Pubitemid 46843340)
5. Weder W, Stahel R, Bernhard J, et al. Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Ann Oncol 2007;18:1196-1202. (Pubitemid 47244366)
6. Batirel H, Metintas M, Caglar H, et al. Trimodality treatment of malignant pleural mesothelioma. J Thorac Oncol 2008;3:499-504. (Pubitemid 351630277)
7. de Perrot M, Feld R, Anraku M, et al. Impact of induction chemotherapy and adjuvant radiation therapy on outcome after extrapleural pneumonectomy for malignant pleural mesothelioma. J Clin Oncol 2007;25(18 Suppl):7708.
8. Pagan V, Ceron L, Paccagnella A, Pizzi G. 5-year prospective results of trimodality treatment for malignant pleural mesothelioma. J Cardiovasc Surg (Torino) 2006;47:595-601. (Pubitemid 44696791)
9. Treasure T, Tan C, Lang-Lazdunski L, Waller D. The MARS trial: mesothelioma and radical surgery. Interact Cardiovasc Thorac Surg 2006;5:58-59. (Pubitemid 43200170)
10. Alvarez J, Ha T, Musk W, Robins P, Price R, Byrne MJ. Importance of mediastinoscopy, bilateral thoracoscopy, and laparoscopy in correct staging of malignant mesothelioma before extrapleural pneumonectomy. J Thorac Cardiovasc Surg 2005;130:905-906. (Pubitemid 41265749)
11. Alvarez J, Hasani A, Segal A, et al. Bilateral thoracoscopy, mediastinoscopy and laparoscopy, in addition to CT, MRI and PET imaging, are essential to correctly stage and treat patients with mesothelioma prior to trimodality therapy. Aus N Z J Surg 2009 In press.
12. Rice D, Erasmus J, Stevens C, et al. Extended surgical staging for potentially resectable malignant pleural mesothelioma. Ann Thorac Surg 2005;80:1988 -1992; discussion 1992-1993. (Pubitemid 41718014)
13. de Perrot M, Uy K, Anraku M, et al. Impact of lymph node metastasis on outcome after extrapleural pneumonectomy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2007;133:111-116. (Pubitemid 46014196)
14. Schouwink J, Kool L, Rutgers E, et al. The value of chest computer tomography and cervical mediastinoscopy in the preoperative assessment of patients with malignant pleural mesothelioma. Ann Thorac Surg 2003;75:1715-1718; discussion 1718-1719. (Pubitemid 36677200)
15. Entwisle J. The use of magnetic resonance imaging in malignant mesothelioma. Lung Cancer 2004;1(45 Suppl):69-71. (Pubitemid 38917117)
16. Musk A, de Klerk N. Epidemiology of malignant mesothelioma in Australia. Lung Cancer 2004;1(45 Suppl):21-23.
17. Department of Health. West Australian Cancer Registry. Perth, Western Australia: Department of Health; 2006.
18. British Thoracic Society, Society of Cardiothoracic Surgeons of Great Britain, Ireland Working Party. BTS guidelines: guidelines on the selection of patients with lung cancer for surgery. Thorax 2001; 56:89-108.
19. Grondin S, Sugarbaker D. Pleuropneumonectomy in the treatment of malignant pleural mesothelioma. Chest 1999;116(Suppl 3):450-454. (Pubitemid 30013155)
20. Nowak A, Byrne M, Williamson R, et al. A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma. Br J Cancer 2002;87:491-496. (Pubitemid 35052715)
21. Rusch V. A proposed new international TNM staging stystem for malignant pleural mesothelioma. Chest 1995;108:1122-1128.
22. Treasure T, Tan C, Peckitt C, et al. Mesothelioma and radical surgery trial (MARS): the feasibility study process. Lung Cancer 2009;63(Suppl 1):26.
23. Weder W, Kestenholz P, Taverna C, et al. Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. J Clin Oncol 2004;22:3451-3457 (Pubitemid 41103650)